Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Recombinant bacteria obtained from Brucella abortus 104-M vaccine strain with Omp25 gene knockout and application

A Brucella and recombinant bacteria technology, applied in the biological field, can solve problems such as abortion, natural infection of antibodies, and vaccine toxicity

Active Publication Date: 2017-10-20
INST OF BIOENG ACAD OF MILITARY MEDICAL SCI OF THE CHINESE
View PDF3 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the attenuated strain of Brucella vaccine is the most effective vaccine to control Brucella in practical application, but most vaccines show certain toxicity, and when used before pregnancy, it will cause abortion, and the antibodies produced by immunity are difficult to be compared with natural infection the difference

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Recombinant bacteria obtained from Brucella abortus 104-M vaccine strain with Omp25 gene knockout and application
  • Recombinant bacteria obtained from Brucella abortus 104-M vaccine strain with Omp25 gene knockout and application
  • Recombinant bacteria obtained from Brucella abortus 104-M vaccine strain with Omp25 gene knockout and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0076] Embodiment 1, the Omp25 gene of knockout Brucella vaccine strain 104M

[0077] In this study, the cloning vector pMD19-T Vector (hereinafter referred to as T vector) was used as the vector to construct the insertional inactivation mutant strain of Brucella. On this basis, the pMD19-T plasmid with the kana resistance gene was constructed, and the deletion mutant strain of Brucella was constructed by replacing the resistance gene. This method avoids the influence of the vector and only needs one time Mutant strains can be obtained through resistance screening. The method of fusion PCR is used to fuse the upstream and downstream homology arms of the gene to be deleted with the kanamycin resistance gene to construct a targeting fragment, wherein the resistance gene is located between the upstream and downstream homology arms of the gene. Then, the targeting fragment is connected to the T vector to construct a mutant vector, and then the deletion mutant strain of Brucella i...

Embodiment 2

[0115] Embodiment 2, the influence of Omp25 gene deletion strain △ Omp25 on bacterial virulence and immunogenicity

[0116] 1. Immunization program

[0117] 1. Determination of immune dose

[0118] To select an appropriate infection dose, 1×10 5 -1×10 8 CFU / mL of 104M bacterial solution was used to inoculate the mice by intraperitoneal inoculation, and the mice were sacrificed at different time points (4-8 days) after infection, the spleen was isolated, and the average spleen weight and the average number of bacteria contained in the spleen per gram were calculated (spleen index =spleen weight (mg) / mouse body weight (g); number of spleen bacteria in grams=total bacterial count in mouse spleen / spleen weight).

[0119] After the mice were immunized with the 104M strain and infected, the mice were observed and sacrificed 4-8 days later, the spleen was isolated, and counted by smearing (see Figure 8 ). No bacteria were isolated from the spleens of mice in the negative contro...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses recombinant bacteria obtained from brucella 104M with Omp25 gene knockout for a vaccine strain and an application. The recombinant bacteria are obtained for reducing and / or inhibiting protein activity of Omp25 in brucella 104M. For the recombinant bacteria, reduction and / or inhibition of protein activity of Omp25 in brucella 104M refer / refers to inhibition or silencing of expression of an Omp25 protein coding gene in brucella 104M. Experiments prove that the recombinant bacteria are obtained by knocking out virulence gene Omp25 from brucella 104M, and delta Omp25 as a brucella attenuated vaccine candidate for human is screened out by means of research in virulence and immunogenicity of the recombinant bacteria.

Description

technical field [0001] The invention relates to the field of biotechnology, in particular to a recombinant bacterium for knocking out the Omp25 gene of a Brucella 104M vaccine strain and its application. Background technique [0002] Brucellosis is a chronic infectious disease caused by Brucella (BruceLLa) infection, and it is also a major zoonotic disease that endangers public health safety worldwide. Among domestic animals, cattle, sheep, and pigs occur most frequently, and can infect humans and other domestic animals. It is characterized by inflammation of reproductive organs and fetal membranes, causing abortion in female animals, infertility in male animals, and local lesions in various tissues. Cattle, sheep, pigs, dogs, etc. are also the main source of infection for human brucellosis. Human infection with brucellosis can cause fever, arthralgia, fatigue and weakness, and some patients turn into chronic patients that are difficult to cure. Brucellosis is widespread a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N1/21C12N15/74A61K39/10A61P31/04C12R1/01
CPCA61K39/098A61K2039/522C07K14/23C12N15/74
Inventor 李山虎王秉翔周建光王莹
Owner INST OF BIOENG ACAD OF MILITARY MEDICAL SCI OF THE CHINESE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com